Live
ACQ
Alora Healthcare Systems
Alora Healthcare Systems→LivTech$300B4dACQ
Warner Bros. Discovery
Warner Bros. Discovery→Paramount Skydance$60B5dACQ
Cursor
Cursor→SpaceX$60B7dACQ
Frontier Communications
Frontier Communications→Verizon$20B6dACQ
Organon & Co.
Organon & Co.→Sun Pharmaceutical Industries$12.5B2dMER
Ascend Federal Credit Union
Ascend Federal Credit Union+LGE Community Credit Union$7B1dMER
Paramount Skydance
Paramount Skydance+Warner Bros. Discovery$110B5dMER
Orient Securities
Orient Securities+Shanghai Securities$86B9dACQ
Norfolk Southern
Norfolk Southern→Union Pacific$85B5dACQ
Kenvue
Kenvue→Kimberly-Clark$48.7B9dSRS
Anthropic
Anthropic$40B2dSRS
Anthropic
Anthropic$40B3dSRS
Anthropic
Anthropic$40B4dACQ
ARC Resources Ltd.
ARC Resources Ltd.→Shell plc$22B1dMER
Delta Air Lines
Delta Air Lines+Northwest Airlines$17B1dACQ
Alora Healthcare Systems
Alora Healthcare Systems→LivTech$300B4dACQ
Warner Bros. Discovery
Warner Bros. Discovery→Paramount Skydance$60B5dACQ
Cursor
Cursor→SpaceX$60B7dACQ
Frontier Communications
Frontier Communications→Verizon$20B6dACQ
Organon & Co.
Organon & Co.→Sun Pharmaceutical Industries$12.5B2dMER
Ascend Federal Credit Union
Ascend Federal Credit Union+LGE Community Credit Union$7B1dMER
Paramount Skydance
Paramount Skydance+Warner Bros. Discovery$110B5dMER
Orient Securities
Orient Securities+Shanghai Securities$86B9dACQ
Norfolk Southern
Norfolk Southern→Union Pacific$85B5dACQ
Kenvue
Kenvue→Kimberly-Clark$48.7B9dSRS
Anthropic
Anthropic$40B2dSRS
Anthropic
Anthropic$40B3dSRS
Anthropic
Anthropic$40B4dACQ
ARC Resources Ltd.
ARC Resources Ltd.→Shell plc$22B1dMER
Delta Air Lines
Delta Air Lines+Northwest Airlines$17B1d
Home·Deals·Biopharmaceutical·Royalty Pharma acquires PTC Therapeutics
Royalty Pharma acquires PTC Therapeutics (2026)
SEO URLwww.firestrike.ai/deals/ptc-therapeutics-royalty-pharma-acquisition-2026
acquisitionAnnounced · Jan 7, 2026BiopharmaceuticalSource · Press ReleaseArticle · Factual
PTC Therapeutics
Royalty Pharma
PTC Therapeutics · Royalty Pharma

Royalty Pharma acquires PTC Therapeutics

David Najork
David Najork · Founding Software Engineer
Published · Updated · 1 min read
ShareXLinkedInEmail
Deal value
$240M
Target
PTC Therapeutics
PTC Therapeutics
Acquirer
Royalty Pharma
Royalty Pharma
Full Acquisition
Status
Completed

Royalty Pharma agreed to acquire PTC Therapeutics. Reported deal value: $240M. Status: Completed. Sector: Biopharmaceutical. Target headquarters context: Location not specified.

This page summarizes publicly available information about the transaction as of 2026-01-07. Figures and status may change as filings and press coverage update.

Explore Firm Details The Life Sciences team guided Royalty Pharma plc on the acquisition of the final portion of PTC Therapeutics ’ remaining royalty on Roche Evrysdi for $240 million upfront

Deal timeline

Announced
Jan 7, 2026 · mondaq.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in Biopharmaceutical with a reported deal value of $240M. Figures and status may change as sources update.

Sources: mondaq.com · Primary article · FireStrike proprietary index